COMMONWEALTH EQUITY SERVICES, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in FULC

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$146,400

-$162,624 QoQ

Shares Held

40,000

-0.7% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#81

of 154 holders

Holding Since

Dec 2023

11 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. FULC ranks #76 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$146,400	40,000	-0.7%	Shares	Sole	2026-07-29
2026-03-31	$309,024	40,290	+0.7%	Shares	Sole	2026-04-27
2025-12-31	$452,400	40,000	-52.1%	Shares	Sole	2026-02-12
2025-09-30	$767,537	83,428	0.0%	Shares	Sole	2025-10-22
2025-06-30	$573,984	83,428	0.0%	Shares	Sole	2025-08-06
2025-03-31	$240,272	83,428	0.0%	Shares	Sole	2025-05-09
2024-12-31	$392,111	83,428	-1.2%	Shares	Sole	2025-02-10
2024-09-30	$301,407	84,428	0.0%	Shares	Sole	2024-10-18
2024-06-30	$523,453	84,428	+1.2%	Shares	Sole	2024-07-31
2024-03-31	$787,560	83,428	-13.5%	Shares	Sole	2024-04-29
2023-12-31	$650,889	96,428	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.